“…We found that the total and indirect bilirubin levels in animals exposed to smoke were significantly lower than in control animals. Emphysema was characterized by increased MLI and MAA, and decreased MAN, infiltration of inflammatory cells and secretion of cytokines such as IL-17, TNF-a, CXCL8, CCL2 and CXCL2 [19,20,27,28]. Bilirubin treatment before exposure to smoke ameliorated the smoke-induced reduction in total and indirect bilirubin and attenuated inflammatory cell recruitment and proinflammatory cytokines secretion, increasing anti-inflammatory cytokine IL-10 levels, and augmenting anti-oxidant SOD activity.…”